Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-25-002635
Filing Date
2025-07-17
Accepted
2025-07-17 21:36:10
Documents
1
Period of Report
2025-07-15

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3682
  Complete submission text file 0000929638-25-002635.txt   5224
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130
Business Address
File Justin J. (Reporting) CIK: 0001726277 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41827 | Film No.: 251132528